D Liebowitz

2.0k citations
14 papers · 1.7k indexed · 1 hit paper · h-index 13
Topics
Viral-associated cancers and disorders (10 papers)Lymphoma Diagnosis and Treatment (8 papers)Eosinophilic Disorders and Syndromes (4 papers)

In The Last Decade

D Liebowitz

14 papers receiving 1.7k citations

Hit Papers

Epstein-Barr virus latent membrane protein (LMP1) and nuc...19902026200220141990100200300400

Peers

D Liebowitz
Comparison fields: 5 of 58
  • Oncology 1.5k
  • Pathology and Forensic Medicine 881
  • Immunology 414
  • Physiology 400
  • Infectious Diseases 362
Replace F Wang with:
F Wang United States
Wendy A. Thomas United Kingdom
F Dallenbach Germany
Lars Santesson Sweden
S Imai Japan
Robert H. Sadler United States
Pathmanathan Rajadurai Malaysia
I Anagnostopoulos Germany
Cosimo G. Sciotto United States
Danny F. Dukers Netherlands
D Liebowitz relative to F Wang United States F Wang's profile →
Citations per field
00.5×1.5×
F Wang · 1×
Citations per year

Countries citing papers authored by D Liebowitz

Since Specialization
Citations

This map shows the geographic impact of D Liebowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Liebowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Liebowitz more than expected).

Fields of papers citing papers by D Liebowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Liebowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Liebowitz. The network helps show where D Liebowitz may publish in the future.

Co-authorship network of co-authors of D Liebowitz

This figure shows the co-authorship network connecting the top 25 collaborators of D Liebowitz. A scholar is included among the top collaborators of D Liebowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Liebowitz. D Liebowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 18
2
Adoptive T-cell therapy.
15
3
The roles of human viruses in the pathogenesis of lymphoma.
66
4 1
5
Nasopharyngeal carcinoma: the Epstein-Barr virus association.
122
6 53
7
Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23breakdown →
496
8 32
9 135
10 51
11 353
12 104
13 103
14 188

About D Liebowitz

D Liebowitz is a scholar working on Pathology and Forensic Medicine, Oncology and Rheumatology, having authored 14 papers that have together received 1.7k indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (10 papers), Lymphoma Diagnosis and Treatment (8 papers) and Eosinophilic Disorders and Syndromes (4 papers). The work is most often cited by research in Oncology (1.5k citations), Pathology and Forensic Medicine (881 citations) and Immunology (414 citations). D Liebowitz has collaborated with scholars based in United States, India and Netherlands. Frequent co-authors include Elliott Kieff, F Wang, Alan B. Rickinson, C D Gregory, Jeffery T. Sample, Clare E. Sample, Martin Rowe, Ryan Murray, Timothy A. Springer and Richard A. Larson. Their work appears in journals such as Molecular and Cellular Biology, Journal of Virology and Bone Marrow Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026